References
- Boyd MR, Paul KD. 1995. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Develop Res. 34: 91–109
- Christian MC, Pluda JM, Ho TC, Arbuck SG, Murgo AJ, Sausville EA. 1997. Promising new agents under development by the Division of Cancer Treatment Diagnosis and the centers of the National Cancer. Inst Seminars in Oncol. 24: 219–240
- Clark A. 1996. Natural products as a resource of new drugs. Pharm Res. 13: 1133–1141. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cragg GM, Newman JD, Snader KM. 1997. National products in drug discovery and development. J Nat Prod. 60: 52–60. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cragg GM, Newman DJ. 1999. Discovery and development of antineoplastic agents from natural sources. Cancer Invest. 17: 153–216. [PUBMED], [INFOTRIEVE], [CSA]
- Correa MD, Valdespino IA. 1998. Flora de Panamá: una de las más ricas y diversas del mundo. ANCON. 5: 16–23. [CSA]
- Fernández T, Wagner M, Varela B, Rico R, Hajos S, Gurni A, Alvarez E. 1998. Study of an Argentine mistletoe, the hemiparasite Ligaria cuneifolia Ret P. Tiegh, (Loranthaceae). J Ethnopharmacol. 62: 25–34. [CSA], [CROSSREF]
- Klerx JPAM, Beukelman CJ, van Dijk H, Willers JMN. 1983. Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. J Immunol Meth. 63: 215–220. [CROSSREF]
- Lee K-H. 1999. Novel antitumor agents from higher plants. Med Res Rev. 19: 569–596. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mann J. 2002. Natural products in cancer chemotherapy: past, present and future. Nature Review, Cancer. 2: 143–148. [CROSSREF]
- Monks A, Scudiero DA, Johnson GS, Pauli KD, Sausville EA. 1997. The NCI-anticancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Design. 12: 533–541
- Monks A, Scudeiro D, Skehan P, Shoemaker R, Pauli K, Vistica D, Hosse C, Langley J, Cronise P, Vaifgro-Wolff A, Gray-Goodrich M, Campbell H, Mayo J, Boyd M. 1991. Feasibility of high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst. 83: 757–766. [PUBMED], [INFOTRIEVE]
- Pezzuto JM. 1997. Plant derived anticancer agents. Biochem Pharmacol. 53: 121–133. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roberts J. 1997. Anticancer drug screening with in vitro models. Drugs of the Future. 22: 739–746
- Seymour L. 1999. Novel anti-cancer agents in development: exciting prospects and new challenges. Cancer Treat Rev. 25: 301–312. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shu Y-Z. 1998. Recent natural products based drug development: A pharmaceutical industry perspective. J Nat Prod. 61: 1053–1071. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Skehan P, Storeng R, Scudeiro D, Monks A, McMahon J, Vistica D, Warren J, Bokesch H, Kenney S, Boyd MR. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 82: 1107–1112. [PUBMED], [INFOTRIEVE]
- Solis PN, Wright CW, Anderson M, Gupta MP, Phillipson JD. 1993. A microwell cytotoxicity assay using Artemia salina (brine shrimp). Planta Med. 59: 250–252. [PUBMED], [INFOTRIEVE]